OBJECTIVE: To determine the risk of death from coronary heart disease, stroke, all cardiovascular disease and all-cause mortality associated with systolic blood pressure and in particular with isolated systolic hypertension among the middle-aged population. METHODS AND DESIGN: A prospective 15-year cohort study of two independent cross-sectional random samples of subjects participating in baseline surveys in 1972 and 1977. Each survey included a self-administered questionnaire, measurements of height, weight and blood pressure and the determination of the serum cholesterol concentration. SETTING: North Karelia and Kuopio provinces in eastern Finland. Mortality follow-up complete with the personal identification number. PARTICIPANTS: Participants were 10,333 men and 11,160 women aged 25-64 years without histories of myocardial infarction and stroke incidence at the time of the baseline survey. Isolated systolic hypertension in these analyses was defined as systolic blood pressure > or = 160 mmHg and diastolic blood pressure < 95 mmHg. Subjects with blood pressure < 160/90 mmHg were considered normotensive. RESULTS: Coronary heart disease, stroke, cardiovascular disease and all-cause mortality among men and women aged 45-64 years increased with the increasing systolic blood pressure. Among women aged 45-64 years, isolated systolic hypertension increased the relative risk of these fatal events. Among men aged 45-64 years, only coronary heart disease mortality was significantly associated with isolated systolic hypertension. CONCLUSION: Isolated systolic hypertension is an important predictor of death from coronary heart disease, stroke, cardiovascular disease and all causes for women. For men aged 45-64 years, the risk of death from coronary heart disease was associated with isolated systolic hypertension, but the risk of stroke, cardiovascular disease and all-cause mortality associated with increasing systolic blood pressure was evident already at the systolic blood pressure levels < 160 mmHg, independently of the level of diastolic blood pressure.
OBJECTIVE: To determine the risk of death from coronary heart disease, stroke, all cardiovascular disease and all-cause mortality associated with systolic blood pressure and in particular with isolated systolic hypertension among the middle-aged population. METHODS AND DESIGN: A prospective 15-year cohort study of two independent cross-sectional random samples of subjects participating in baseline surveys in 1972 and 1977. Each survey included a self-administered questionnaire, measurements of height, weight and blood pressure and the determination of the serum cholesterol concentration. SETTING: North Karelia and Kuopio provinces in eastern Finland. Mortality follow-up complete with the personal identification number. PARTICIPANTS: Participants were 10,333 men and 11,160 women aged 25-64 years without histories of myocardial infarction and stroke incidence at the time of the baseline survey. Isolated systolic hypertension in these analyses was defined as systolic blood pressure > or = 160 mmHg and diastolic blood pressure < 95 mmHg. Subjects with blood pressure < 160/90 mmHg were considered normotensive. RESULTS:Coronary heart disease, stroke, cardiovascular disease and all-cause mortality among men and women aged 45-64 years increased with the increasing systolic blood pressure. Among women aged 45-64 years, isolated systolic hypertension increased the relative risk of these fatal events. Among men aged 45-64 years, only coronary heart disease mortality was significantly associated with isolated systolic hypertension. CONCLUSION: Isolated systolic hypertension is an important predictor of death from coronary heart disease, stroke, cardiovascular disease and all causes for women. For men aged 45-64 years, the risk of death from coronary heart disease was associated with isolated systolic hypertension, but the risk of stroke, cardiovascular disease and all-cause mortality associated with increasing systolic blood pressure was evident already at the systolic blood pressure levels < 160 mmHg, independently of the level of diastolic blood pressure.
Authors: Amit R Nayak; Shweta R Badar; Neha Lande; Anuja P Kawle; Dinesh P Kabra; Nitin H Chandak; Dhananjay V Raje; Lokendra R Singh; Hatim F Daginawala; Rajpal S Kashyap Journal: Ann Neurosci Date: 2016-10-04
Authors: Grace H Lo; Timothy E McAlindon; Jeffrey N Katz; Jeffrey B Driban; Lori Lyn Price; Charles B Eaton; Nancy J Petersen; Christie M Ballantyne; Maria E Suarez-Almazor Journal: Clin Rheumatol Date: 2017-06-01 Impact factor: 2.980
Authors: Pedro Gomes; Sónia Simão; Elisabete Silva; Vanda Pinto; João S Amaral; Joana Afonso; Maria Paula Serrão; Maria João Pinho; Patrício Soares-da-Silva Journal: Oxid Med Cell Longev Date: 2009 Jul-Aug Impact factor: 6.543
Authors: Sanna-Maria Michou; Mika Kähönen; Terho Lehtimäki; Kjell Nikus; Jari Viik; Kari Niemelä; Janne Kallio; Rami Lehtinen; Tiit Kööbi; Väinö Turjanmaa; Tuomo Nieminen Journal: Clin Drug Investig Date: 2007 Impact factor: 2.859
Authors: Stacie L Daugherty; Frederick A Masoudi; Chan Zeng; P Michael Ho; Karen L Margolis; Patrick J O'Connor; Alan S Go; David J Magid Journal: J Hypertens Date: 2013-02 Impact factor: 4.844